Lancaster General Health Plans to Expand Cancer Center
Lancaster General Health is planning a $38 million expansion of their cancer center.
Some cancer drugs are great at keeping patients in remission, but they don’t know about them– or don’t want to take them
There are four anti-cancer drugs that are effective, but rarely taken because of their harsh side effects.
Woman Sues Wilkes-Barre General Hospital for Testing Wrong Kidney
Renee Deyo is suing Wilkes Barre General Hospital for allowing a treatable form of cancer to spread because they conducted tests on the wrong kidney multiple times.
Less Agreesive Methods of Bone Marrow Transplants May Lead to More Uses
New methods of bone marrow transplants are less invasive and offer more hope for individuals suffering from a variety of diseases.
New study contends that increased breast cancer screening does not result in decreased death rates
The study is sure to add fuel to the fire over breast cancer screening guidelines.
New blood test of tumors to find out their DNA may create more effective treatment plans
The findings suggest that by testing blood for this fingerprint, doctors will be able to learn whether a patient treated for cancer is free of disease or needs additional or more aggressive care, reports the Wall Street Journal.
New study suggests that aspirin use may reduce risk of death from breast cancer
In the study, reports Reuters, women who took aspirin two to five days a week had a 60 percent reduced risk of their cancer spreading and a 71 percent lower risk of breast cancer death. Six to seven aspirins a week lowered the risk of spread by 43 percent and the risk of breast cancer death by 64 percent.
Cytokinetics ends cancer deal with GlaxoSmithKline
Philadelphia Inq reports:
NEW YORK – Cytokinetics Inc. said Wednesday it ended a deal with GlaxoSmithKline PLC that had focused on developing a potential cancer treatment, sending shares sharply lower in after-hours trading.
Cytokinetics said, effective Feb. 28, all rights for the potential cancer treatment GSK-923295 will revert back to the biotechnology company. GlaxoSmithKline will still be [...]
Results of one study of PA cancer cluster are back; but they’re inconclusive
Thirty-three people in a 20-mile stretch between Hazleton and Tamaqua have a specific type of rare blood cancer.
Study says there’s no link between brain tumors and cell phone usage
Hopefully, the study’s findings will ease people’s fears.